Accéder au contenu
Merck

Quantifying EGFR endosomal recycling via immunofluorescence in breast cancer cells.

STAR protocols (2022-05-03)
Ana Lonic, Winona Onglao, Yeesim Khew-Goodall
RÉSUMÉ

Previously published protocols for quantification of endosomal recycling are limited by the use of radioactive reagents, washing of cells in reducing buffers, or the requirement for large numbers of cells. Here, we describe a protocol for quantification of endosomal recycling using immunofluorescence that is optimized for EGFR in BT-549 breast cancer cells but could be applied to other RTKs and cell lines. Our protocol enables quick assessment of recycling and uses a relatively small number of cells. For complete details on the use and execution of this protocol, please refer to Lonic et al. (2021).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, BioReagent, suitable for cell culture
Roche
Fibronectine, from human plasma